Lotus Holdings News

Lotus Holdings (600186): The trend of organizational change has come to a standstill, awaiting Nirvana

Jul 23 00:00

Lotus Holdings (600186): Profitability increased significantly, and the second growth curve began to gain strength

Jun 30 00:00

Research and Development | Huaxin Securities: Lotus Health continues internal reforms and actively develops a second growth curve

Gelonghui FinanceJan 11 16:49

Lotus Health (600186): The path to building the foundation of the brand is clear in the second spring of Laoshu and Xinhua

Jan 11 09:16

Research Nuggets丨Huaxin Securities: Lotus Health Acquires WeizhiLi to Accelerate Overseas Expansion and Maintain a “Buy” Rating

Gelonghui FinanceDec 28, 2023 17:39

Lotus Health (600186): Acquisition of Weizhi Force accelerates overseas layout, organizational structure adjustments, and clarifies division of labor

Dec 28, 2023 11:22

Lotus Health (600186): Excellent basic market performance, second growth curve is worth looking forward to

Oct 29, 2023 00:00

Lotus Health (600186): Third-quarter results exceeded expectations, focusing on the second growth curve

Oct 13, 2023 00:00

Lotus Health (600186): Main business restoration and high growth explores the second growth curve of computing power

Sep 21, 2023 00:00

Lotus Health (600186): Performance meets expectations Lotus begins a new chapter

華鑫證券Aug 31, 2023 18:32

Lotus Health (600186): Equity incentives highlight confidence and restart the innovation journey

東方財富證券Aug 11, 2023 15:51

Lotus Health (600186) Quarterly report comments: reduction of subsidies resulting in a single-quarter loss increase long-term layout of green health industry chain

中信建投Nov 2, 2016 00:00

[CSC FINANCIAL CO.,LTD] Lotus Health: the reduction of subsidies leads to an increase in losses in a single quarter, and the long-term layout of the green health industrial chain

中信建投證券Oct 31, 2016 00:00

[Galaxy Securities] Lotus Monosodium glutamate: open Nirvana and imagine expectation

中國銀河Oct 10, 2014 00:00

Lotus Monosodium glutamate (600186): waiting for the third quarter results to be announced

紅塔證券Dec 6, 2012 00:00

[Hongta Securities] Lotus Monosodium Glutamate: Waiting for the third quarter results to be announced

紅塔證券Oct 11, 2012 00:00

[Tianxiang Investment] Lotus monosodium glutamate: performance is still low

天相投資Oct 25, 2011 00:00

[century Securities] Lotus monosodium glutamate: stimulated by the auction of major shareholders' shares and skyrocketing product prices

世紀證券Nov 23, 2009 00:00

[Tianxiang Investment] Lotus monosodium glutamate: the decline in expense rate leads to an increase in company profits.

天相投資Nov 1, 2009 00:00

[Changjiang Securities] Lotus Monosodium glutamate (600186): research and Review of KuaiBao and Annual report

長江證券Apr 30, 2007 00:00